SLC35A2 and neoplasm: At first, the results on GEPIA and TISIDB websites indicated the influence of different immune subtypes (C1, C2, C3, C4, C6, P = 1.17e-08) and molecular subtypes (CIN, EBV, GS, HM-SNV, HM-indel, P = 1.6e-08) the independence of on SLC35A2 expression, despite its independence of tumor stage (P = 0.196) (S1 Fig).